EGFR-NSCLC Market: Current Analysis and Forecast (2023-2030)

Report Description

The EGFR-NSCLC Market was valued at USD 6762.75 million in the year 2022 and is expected to grow at a strong CAGR of around 6.7% during the forecast period (2023-2030). EGFR-non-small cell lung cancer (NSCLC) is a type of lung cancer that has a specific genetic mutation in the epidermal growth factor receptor (EGFR) gene. NSCLC is the more common of the two types of lung cancer. As per the American Cancer Society 2019, about 80% to 85% of lung cancers are NSCLC. This mutation can be targeted by EGFR-targeted therapies, which have been shown to improve survival outcomes for patients with EGFR-positive NSCLC. Furthermore, as per the article published by the Cancer Treatment Centers of America in 2022 on lung cancer types, lung adenocarcinoma is the most common form of lung cancer, accounting for 30% of all cases overall and about 40% of all non-small cell lung cancer occurrences. As per the same source, squamous cell lung cancer accounts for about 30% of all non-small cell lung cancers and is commonly associated with smoking. In most cases of NSCLC, large-cell undifferentiated carcinoma accounts for 10% to 15% of all cases. These all factors are contributing to the growth of the market during the forecast period.

Some of the major players operating in the market include F. Hoffmann-La Roche Ltd; Boehringer Ingelheim International GmbH; AstraZeneca; Pfizer Inc.; Novartis AG; Johnson & Johnson Services, Inc.; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Genentech, Inc.; Astellas Pharma Inc. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst drug type, the osimertinib drug category dominates the market’s growth and continues to grow at a significant rate during the forecast period”

Based on drug type, the market is segmented into erlotinib, afatinib, gefitinib, osimertinib, and dacomitinib. Among them, the osimertinib drug category dominates the market’s growth and continues to grow at a significant rate during the forecast period. This is mainly due to the high response rates and prolonged survival in patients, minimizing side effects and toxicity, safety profile compared to other EGFR-TKIs, with a low incidence of serious adverse events, and Tagrisso has demonstrated a median overall survival (OS) of 31.4 months in patients with EGFR-mutated NSCLC, making it one of the longest-lasting EGFR-TKIs available.

“Amongst distribution channel, the offline category is expected to dominate the EGFR-NSCLC market during the forecast period”

Based on distribution channel, the market is segmented into online and offline. Among them, the offline category is expected to dominate the EGFR-NSCLC market during the forecast period. This is mainly due to the rising patient pool in hospitals or rising awareness in emerging countries for diagnosis of life-threatening diseases like lung cancer driving the growth of this market during the forecast period. For instance, according to the American Society of Clinical Oncology, lung cancer is the second most common cancer and approximately 235,760 adults (119,100 men and 116,660 women) in the United States will be diagnosed with lung cancer by the end of 2021.

“North America dominated the EGFR-NSCLC Market in 2022”

North America region is expected to dominate the EGFR-NSCLC market during the forecast period. The region’s robust healthcare infrastructure, coupled with high awareness levels among patients and healthcare providers, has spurred the demand for advanced treatment options. The prevalence of non-small cell lung cancer cases with EGFR mutations has prompted pharmaceutical companies to focus on R&D, resulting in the introduction of innovative targeted therapies. For Instance, as per the American Cancer Society, about 238,340 new cases of lung cancer (117,550 in men and 120,790 in women) were diagnosed in 2023 till now.

EGFR-NSCLC Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global EGFR-NSCLC market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the EGFR-NSCLC Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global EGFR-NSCLC Market were the three major steps undertaken to create and analyze the adoption of smart homes in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global EGFR-NSCLC Market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the EGFR-NSCLC Market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the EGFR-NSCLC Market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as drug type and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the EGFR-NSCLC Market. Further, we conducted factor analysis using dependent and independent variables such as drug type and distribution channel of the EGFR-NSCLC Market. A thorough analysis was conducted of demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the EGFR-NSCLC Market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global EGFR-NSCLC Market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the EGFR-NSCLC Market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global EGFR-NSCLC Market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global EGFR-NSCLC Market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the drug type and distribution channel in the global EGFR-NSCLC Market.

The main objective of the Global EGFR-NSCLC Market Study

The current & future market trends of the global EGFR-NSCLC Market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the EGFR-NSCLC Market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
• Segments in the study include areas of the drug type and distribution channel.
• Define and analysis of the regulatory framework for the smart home
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the EGFR-NSCLC Market for the major region.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the EGFR-NSCLC Market and the growth strategies adopted by the market players to sustain in the fast-growing market.
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team